SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics.

Panahi, M; Hase, Y; Gallart-Palau, X; Mitra, S; Watanabe, A; Low, RC; Yamamoto, Y; Sepulveda-Falla, D; Hainsworth, AH; Ihara, M; et al. Panahi, M; Hase, Y; Gallart-Palau, X; Mitra, S; Watanabe, A; Low, RC; Yamamoto, Y; Sepulveda-Falla, D; Hainsworth, AH; Ihara, M; Sze, SK; Viitanen, M; Behbahani, H; Kalaria, RN (2023) ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics. Acta Neuropathol Commun, 11 (1). p. 76. ISSN 2051-5960 https://doi.org/10.1186/s40478-023-01558-1
SGUL Authors: Hainsworth, Atticus Henry

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (4MB) | Preview
[img] Microsoft Word (.doc) (Supplementary Material 1) Published Version
Available under License Creative Commons Attribution.

Download (4MB)
[img] Microsoft Excel (Supplementary Material 2) Published Version
Available under License Creative Commons Attribution.

Download (115kB)
[img] Microsoft Excel (Supplementary Material 3) Published Version
Available under License Creative Commons Attribution.

Download (179kB)
[img] Microsoft Excel (Supplementary Material 4) Published Version
Available under License Creative Commons Attribution.

Download (150kB)
[img] Microsoft Excel (Supplementary Material 5) Published Version
Available under License Creative Commons Attribution.

Download (173kB)
[img] Microsoft Excel (Supplementary Material 6) Published Version
Available under License Creative Commons Attribution.

Download (180kB)
[img] Microsoft Excel (Supplementary Material 7) Published Version
Available under License Creative Commons Attribution.

Download (143kB)

Abstract

Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is caused by NOTCH3 mutations. Typical CADASIL is characterised by subcortical ischemic strokes due to severe arteriopathy and fibrotic thickening of small arteries. Arteriolar vascular smooth muscle cells (VSMCs) are the key target in CADASIL, but the potential mechanisms involved in their degeneration are still unclear. Focusing on cerebral microvessels in the frontal and anterior temporal lobes and the basal ganglia, we used advanced proteomic and immunohistochemical methods to explore the extent of inflammatory and immune responses in CADASIL subjects compared to similar age normal and other disease controls. There was variable loss of VSMC in medial layers of arteries in white matter as well as the cortex, that could not be distinguished whether NOTCH3 mutations were in the epidermal growth factor (EGFr) domains 1-6 or EGFr7-34. Proteomics of isolated cerebral microvessels showed alterations in several proteins, many associated with endoplasmic reticulum (ER) stress including heat shock proteins. Cerebral vessels with sparsely populated VSMCs also attracted robust accrual of perivascular microglia/macrophages in order CD45+ > CD163+ > CD68+cells, with > 60% of vessel walls exhibiting intercellular adhesion molecule-1 (ICAM-1) immunoreactivity. Functional VSMC cultures bearing the NOTCH3 Arg133Cys mutation showed increased gene expression of the pro-inflammatory cytokine interleukin 6 and ICAM-1 by 16- and 50-fold, respectively. We further found evidence for activation of the alternative pathway of complement. Immunolocalisation of complement Factor B, C3d and C5-9 terminal complex but not C1q was apparent in ~ 70% of cerebral vessels. Increased complement expression was corroborated in > 70% of cultured VSMCs bearing the Arg133Cys mutation independent of N3ECD immunoreactivity. Our observations suggest that ER stress and other cellular features associated with arteriolar VSMC damage instigate robust localized inflammatory and immune responses in CADASIL. Our study has important implications for immunomodulation approaches to counter the characteristic arteriopathy of CADASIL.

Item Type: Article
Additional Information: © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Keywords: CADASIL, Complement, Interleukin 6, Intracellular adhesion molecule, Stroke, Vascular smooth muscle cells, Humans, CADASIL, Intercellular Adhesion Molecule-1, Proteomics, Complement System Proteins, Cerebral Infarction, Humans, Cerebral Infarction, CADASIL, Intercellular Adhesion Molecule-1, Proteomics, Complement System Proteins, CADASIL, Complement, Interleukin 6, Intracellular adhesion molecule, Stroke, Vascular smooth muscle cells, 0601 Biochemistry and Cell Biology, 1103 Clinical Sciences, 1109 Neurosciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Acta Neuropathol Commun
ISSN: 2051-5960
Language: eng
Dates:
DateEvent
8 May 2023Published
26 March 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
RF1NS110048NIA NIH HHSUNSPECIFIED
G0500247Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
G0400074Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
UNSPECIFIEDDepartment of HealthUNSPECIFIED
PI22/00443Instituto de Salud Carlos IIIhttp://dx.doi.org/10.13039/501100004587
CP21/00096Instituto de Salud Carlos IIIhttp://dx.doi.org/10.13039/501100004587
PubMed ID: 37158955
Web of Science ID: WOS:000984025100001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115655
Publisher's version: https://doi.org/10.1186/s40478-023-01558-1

Actions (login required)

Edit Item Edit Item